This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Hydroxychloroquine sulfate

Read time: 1 mins
Marketing start date: 20 Apr 2024

Summary of product characteristics


Effective Time

20221012

Version

6

Spl Product Data Elements

Hydroxychloroquine sulfate Hydroxychloroquine sulfate HYDROXYCHLOROQUINE SULFATE HYDROXYCHLOROQUINE DIBASIC CALCIUM PHOSPHATE DIHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POLYVINYL ALCOHOL, UNSPECIFIED TALC TITANIUM DIOXIDE STARCH, CORN WHITE TO OFF-WHITE CAPSULE ZC38

Application Number

ANDA040657

Brand Name

Hydroxychloroquine sulfate

Generic Name

Hydroxychloroquine sulfate

Product Ndc

65841-633

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-633-01 in bottle of 100 tablets Hydroxychloroquine Sulfate Tablets USP, 200 mg R x only 100 tablets Hydroxychloroquine sulfate tablets

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.